Discovery of n,4-di(1h-pyrazol-4-yl)pyrimidin-2-amine- derived cdk2 inhibitors as potential anticancer agents: design, synthesis, and evaluation

HIGHLIGHTS

• who: Biruk Sintayehu Fanta and colleagues from the Drug Discovery and Development, Clinical and Health Sciences, University of South Australia have published the research: Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine- Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation, in the Journal: Molecules 2023, 28,damage. x FOR PEER REVIEW The DNA of /2023/
• what: The authors report the substituting the phenylsulfonamide moiety of 1 with a pyrazole motif. The authors report preparation andand evaluation of N,4-di(1H-pyrazol-4-yl)pyrimidin-2-amine derivatives . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.